News tagged with anticancer drugs
Related topics: cancer , cancer cells , tumor cells , cancer drugs
A new approach to improving cancer chemotherapy
(Medical Xpress) -- Chemotherapy kills tumor cells, but it also wreaks havoc on the rest of the body. A team of researchers led by Igor Roninson of the South Carolina College of Pharmacy just reported the discovery of a new ...
Cancer
Aug 07, 2012 |
5 / 5 (2) |
0
|
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.
Cancer
May 24, 2012 |
4.7 / 5 (55) |
5
|
New fractionated dosing regimen for anticancer drug significantly improves outcomes for older leukemia patients
Using fractionated doses of the targeted anticancer drug gemtuzumab ozogamicin allows for safer delivery of the drug into patients aged 50-70 years with acute myeloid leukaemia (AML) and substantially improves their outcomes. ...
Cancer
Apr 04, 2012 |
5 / 5 (1) |
0
First volume of the Cancer Cell Line Encyclopedia made public
The goal of cancer treatment is to match the right drug to the right target in the right patient. But before such "personalized" drugs can be developed, more knowledge is needed about specific genomic alterations in cancers ...
Cancer
Mar 28, 2012 |
5 / 5 (1) |
0
|
The path to personalized cancer treatment
In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments. The study is published in Nature on Thursday 29 Mar ...
Cancer
Mar 28, 2012 |
5 / 5 (2) |
0
|
Hot on the trail of metabolic diseases and resistance to antibiotics
Proteins belonging to the large and important family of ABC transporters have been associated with metabolic diseases and can cause resistance to antibiotics. Biochemists from the University of Zurich and the NCCR Structural ...
Medical research
Mar 28, 2012 |
not rated yet |
0
Using metabolic 'pollution' to target improved anticancer treatments
Advances in chemotherapy have dramatically improved the outlook for many cancer patients, but the side effects of this treatment are daunting. A new generation of chemotherapy drugs with fewer side effects ...
Cancer
Mar 26, 2012 |
not rated yet |
0
Energy network within cells may be new target for cancer therapy
Mitochondria, tiny structures within each cell that regulate metabolism and energy use, may be a promising new target for cancer therapy, according to a new study. Manipulation of two biochemical signals that regulate the ...
Cancer
Feb 21, 2012 |
5 / 5 (1) |
0
|
Turning the spotlight on drug-resistant tumors
Molecular probes that can illuminate cancer cells are often invaluable tools in the fight against the disease. The latest addition to this group is a family of fluorescent probes that can highlight a particularly ...
Cancer
Dec 09, 2011 |
not rated yet |
0
Neurotransmitter might improve cancer treatment: study
Doses of a neurotransmitter might offer a way to boost the effectiveness of anticancer drugs and radiation therapy, according to a new study led by researchers at the Ohio State University Comprehensive Cancer Center – ...
Cancer
Dec 05, 2011 |
5 / 5 (2) |
0
|
Through-the-nipple breast cancer therapy shows promise in early tests
Delivering anticancer drugs into breast ducts via the nipple is highly effective in animal models of early breast cancer, and has no major side effects in human patients, according to a report by Johns Hopkins Kimmel Cancer ...
Cancer
Oct 26, 2011 |
5 / 5 (2) |
0
|
Peptides for fighting ovarian cancer developed
A team of German and Italian EU-funded scientists has designed peptides that can target the protein-protein interface of an enzyme that plays a key part in the DNA synthesis crucial for cancer growth.
Cancer
Aug 08, 2011 |
not rated yet |
0
|
Mechanism of action behind novel cancer agents targeting tumor cell metabolism discovered
(Medical Xpress) -- The discovery of the mechanism of action behind a novel class of anticancer drugs designed to disrupt cancer cell mitochondrial metabolism may be a major step toward furthering clinical trials of the agents. ...
Cancer
Jul 26, 2011 |
5 / 5 (4) |
0
|
PXR: A stepping stone from environmental chemical to cancer?
Several chemicals that can accumulate to high levels in our body (for example BPA and some pesticides) have been recently linked to an increased risk of cancer and/or impaired responsiveness to anticancer drugs. A team of ...
Cancer
Jul 11, 2011 |
5 / 5 (1) |
0
Antifungal drug delays need for chemo in advanced prostate cancer
The oral antifungal drug itraconazole, most commonly used to treat nail fungus, may keep prostate cancer from worsening and delay the need for chemotherapy in men with advanced disease. Details of the finding, from a clinical ...
Cancer
Jun 02, 2011 |
not rated yet |
0
